84 related articles for article (PubMed ID: 14656458)
1. An alternative genetic method to test essential vaccinia virus early genes.
Kato SE; Greco FA; Damaso CR; Condit RC; Moussatché N
J Virol Methods; 2004 Jan; 115(1):31-40. PubMed ID: 14656458
[TBL] [Abstract][Full Text] [Related]
2. Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy.
Boulanger D; Baier R; Erfle V; Sutter G
J Virol Methods; 2002 Oct; 106(1):141-51. PubMed ID: 12367739
[TBL] [Abstract][Full Text] [Related]
3. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses.
Isaacs SN; Kotwal GJ; Moss B
Virology; 1990 Oct; 178(2):626-30. PubMed ID: 2219714
[TBL] [Abstract][Full Text] [Related]
4. A dominant selectable marker for the construction of recombinant poxviruses.
Boyle DB; Coupar BE
Gene; 1988 May; 65(1):123-8. PubMed ID: 2840353
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: evidence that the gene is essential for virus growth.
Shuman S; Golder M; Moss B
Virology; 1989 May; 170(1):302-6. PubMed ID: 2541548
[TBL] [Abstract][Full Text] [Related]
6. Transient selection during vaccinia virus recombination with insertion vectors without selectable markers.
Kurilla MG
Biotechniques; 1997 May; 22(5):906-10. PubMed ID: 9149873
[TBL] [Abstract][Full Text] [Related]
7. Construction and isolation of recombinant vaccinia virus using genetic markers.
Lorenzo MM; Galindo I; Blasco R
Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus gene SalF5R is non-essential for virus replication in vitro and in vivo.
Duncan SA; Smith GL
J Gen Virol; 1992 May; 73 ( Pt 5)():1235-42. PubMed ID: 1588324
[TBL] [Abstract][Full Text] [Related]
9. Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.
Greaves RF; Brown JM; Vieira J; Mocarski ES
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2151-60. PubMed ID: 7561752
[TBL] [Abstract][Full Text] [Related]
10. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes.
Zhou J; Crawford L; McLean L; Sun XY; Stanley M; Almond N; Smith GL
J Gen Virol; 1990 Sep; 71 ( Pt 9)():2185-90. PubMed ID: 2170578
[TBL] [Abstract][Full Text] [Related]
11. Transient dominant selection of recombinant vaccinia viruses.
Falkner FG; Moss B
J Virol; 1990 Jun; 64(6):3108-11. PubMed ID: 2159565
[TBL] [Abstract][Full Text] [Related]
12. The vaccinia virus F11L gene product facilitates cell detachment and promotes migration.
Morales I; Carbajal MA; Bohn S; Holzer D; Kato SE; Greco FA; Moussatché N; Krijnse Locker J
Traffic; 2008 Aug; 9(8):1283-98. PubMed ID: 18485055
[TBL] [Abstract][Full Text] [Related]
13. Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.
Smith KA; Stallard V; Roos JM; Hart C; Cormier N; Cohen LK; Roberts BE; Payne LG
Vaccine; 1993; 11(1):43-53. PubMed ID: 8427036
[TBL] [Abstract][Full Text] [Related]
14. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
[TBL] [Abstract][Full Text] [Related]
15. Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling.
Valderrama F; Cordeiro JV; Schleich S; Frischknecht F; Way M
Science; 2006 Jan; 311(5759):377-81. PubMed ID: 16424340
[TBL] [Abstract][Full Text] [Related]
16. Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus.
Scheiflinger F; Dorner F; Falkner FG
Arch Virol; 1998; 143(3):467-74. PubMed ID: 9572548
[TBL] [Abstract][Full Text] [Related]
17. The vaccinia virus bifunctional gene J3 (nucleoside-2'-O-)-methyltransferase and poly(A) polymerase stimulatory factor is implicated as a positive transcription elongation factor by two genetic approaches.
Latner DR; Xiang Y; Lewis JI; Condit J; Condit RC
Virology; 2000 Apr; 269(2):345-55. PubMed ID: 10753713
[TBL] [Abstract][Full Text] [Related]
18. A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning.
Turner PC; Moyer RW
Biotechniques; 1992 Nov; 13(5):764-71. PubMed ID: 1418979
[TBL] [Abstract][Full Text] [Related]
19. Inducible gene expression from vaccinia virus vectors.
Rodriguez JF; Smith GL
Virology; 1990 Jul; 177(1):239-50. PubMed ID: 2191497
[TBL] [Abstract][Full Text] [Related]
20. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1.
Zhou JA; McIndoe A; Davies H; Sun XY; Crawford L
Virology; 1991 Mar; 181(1):203-10. PubMed ID: 1847256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
